Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
BFNHBioforce Nanosciences Holdings, Inc.
Filed May 19, 2026 · 10-Q · 49 days after period end · 0001091818-26-000077
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$102.41K | -$935.46K | -$130.81K | -$130.01K |
| EPS Diluted | $0.00 | -$0.03 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 19, 2026 · 49 d after period end
